EBP and skeletal dysplasia: The child underwent initial evaluation in the genetics consultation, where genetic testing using whole-exome sequencing (WES) based on next-generation sequencing (NGS), targeting a panel of genes associated with skeletal dysplasia, identified a heterozygous loss-of-function (LoF) variant in the emopamil-binding protein (EBP) gene.